Skip to Content

Stericycle Inc SRCL Stock Quote

| Rating as of

Morningstar‘s Stock Analysis SRCL

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Stericycle's Q2 Featured Solid Organic Revenue Growth and Sequential Margin Improvement

Business Strategy and Outlook

| Brian Bernard, CFA, CPA |

Since its founding in 1989, Stericycle has been extremely acquisitive, having acquired over 500 companies. On the surface, this acquisitive strategy led to a lengthy period of impressive growth and the firm built unmatched scale. However, acquisitions began to stray from Stericycle's core competencies and poor integration efforts caused inefficiencies to build. After decades of strong growth and profitability, Stericycle's financial performance began to deteriorate in 2017.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SRCL

Company Profile SRCL

Business Description

Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $76 million of sales in fiscal 2021 (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.

Contact
2355 Waukegan Road
Bannockburn, IL, 60015
T +1 847 367-5910
Industry Waste Management
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 15,000

Related News SRCL